174 related articles for article (PubMed ID: 31729971)
1. Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials.
Huh J; Ham SJ; Cho YC; Park B; Kim B; Woo CW; Choi Y; Woo DC; Kim KW
BMC Med Imaging; 2019 Nov; 19(1):89. PubMed ID: 31729971
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats.
Zhang W; Kong X; Wang ZJ; Luo S; Huang W; Zhang LJ
PLoS One; 2015; 10(6):e0129621. PubMed ID: 26076199
[TBL] [Abstract][Full Text] [Related]
3. Assessing Liver Function by T1 Maps on Gd-EOB-DTPA-Enhanced MRI for up to 50 Min in Rat Models of Liver Fibrosis: A Longer Hepatobiliary Time Period may Help.
Xu J; Wang X; Jin ZY; Wang Q; You Y; Wang ST; Qian TY; Xue HD
Chin Med Sci J; 2021 Jun; 36(2):110-119. PubMed ID: 34231459
[TBL] [Abstract][Full Text] [Related]
4. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.
Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B
Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.
Zhang W; Chen HJ; Wang ZJ; Huang W; Zhang LJ
Eur Radiol; 2017 May; 27(5):2086-2094. PubMed ID: 27488851
[TBL] [Abstract][Full Text] [Related]
6. Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis.
Giraudeau C; Leporq B; Doblas S; Lagadec M; Pastor CM; Daire JL; Van Beers BE
Eur Radiol; 2017 May; 27(5):1804-1811. PubMed ID: 27553933
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI.
Wu Z; Cheng ZL; Yi ZL; Xie MW; Zeng H; Lu LJ; Xu X; Shen J
J Magn Reson Imaging; 2017 May; 45(5):1485-1493. PubMed ID: 27606822
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging.
Hako R; Kristian P; Jarčuška P; Haková I; Hockicková I; Schréter I; Janičko M
Can J Gastroenterol Hepatol; 2019; 2019():3024630. PubMed ID: 31058108
[No Abstract] [Full Text] [Related]
10. Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI.
Jang YJ; Cho SH; Bae JH; Kim GC; Ryeom H; Kim HJ; Shin KM; Lee HJ
Ann Hepatol; 2013; 12(6):926-34. PubMed ID: 24114823
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-To.
Chen YW; Tsai MY; Pan HB; Tseng HH; Hung YT; Chou CP
PLoS One; 2014; 9(12):e114756. PubMed ID: 25490034
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection.
Dyvorne HA; Jajamovich GH; Bane O; Fiel MI; Chou H; Schiano TD; Dieterich D; Babb JS; Friedman SL; Taouli B
Liver Int; 2016 May; 36(5):659-66. PubMed ID: 26744140
[TBL] [Abstract][Full Text] [Related]
13. [Gadolinium Ethoxybenzyl Diethylene-triamine-pentaacetic-acid-enhanced Magnetic Resonance Imaging Perfusion and Multiple Hepatobiliary-phase Imaging for Quantitative Assessment of Liver Fibrosis in Rat Models].
Xu J; Wang X; You Y; Xue HD; Wang Q; Wang ST; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):809-816. PubMed ID: 30606393
[TBL] [Abstract][Full Text] [Related]
14. Four indices on Gd-EOB-DTPA-enhanced MRI can estimate liver functional reserve compared to ICG-R15: A systematic review and meta-analysis.
Ai X; Wang H; Yang Y; Feng Y; Xie X; Zhao X; Li J; Yao P; Zhu Q
Clin Imaging; 2023 Oct; 102():1-8. PubMed ID: 37437466
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J
Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204
[TBL] [Abstract][Full Text] [Related]
16. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA.
Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K
J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439
[TBL] [Abstract][Full Text] [Related]
17. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
18. Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min.
Zhou ZP; Long LL; Huang LJ; Yang TF; Huang ZK
Radiol Med; 2017 Apr; 122(4):239-247. PubMed ID: 28070844
[TBL] [Abstract][Full Text] [Related]
19. Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis.
Keller S; Aigner A; Zenouzi R; Kim AC; Meijer A; Weidemann SA; Krech T; Lohse AW; Adam G; Schramm C; Yamamura J
PLoS One; 2018; 13(3):e0193929. PubMed ID: 29513767
[TBL] [Abstract][Full Text] [Related]
20. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.
Scotcher D; Melillo N; Tadimalla S; Darwich AS; Ziemian S; Ogungbenro K; Schütz G; Sourbron S; Galetin A
Mol Pharm; 2021 Aug; 18(8):2997-3009. PubMed ID: 34283621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
